Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing"
Post a Comment